According to Future Market Insights’ newly released Genomics Market industry analysis report, global sales of Genomics in 2021 will be valued at US$ 24.3 billion. The projected market growth rate from 2022 to 2032 is 19.8%, which is significantly higher than the historical rate. Functional Genomics is expected to be the highest revenue-generating type, with a CAGR of 23% between 2022 and 2032.
Using scientific studies and existing databases of genetic information, scientists investigated genetic vulnerability and intensity to coronavirus disease 2. The use of genomic modelling and multiomic approaches in genome-wide association studies (GWAS) has revealed various biological networks and social influences on diseases.
Similarly, genomic data such as polygenic risk scores (PRS), ABO blood groups, and HLA haplotypes can be used to identify comorbidities, resistance, and susceptibility in COVID-19 patients. Biobanks that link electronic health records (EHRs) to genetic data can be used to investigate the relationship between genomic factors in the health histories of suspected SARS-CoV-2 patients.
Request Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15958
Crucial information and forecast statistics covered in the Genomics market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.
COVID-19 Impact Analysis on Genomics Market
The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Genomics market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Genomics market.
Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.
The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Genomics market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.
Why Choose Future Market Insights
- Serving domestic and international clients 24/7
- Prompt and efficient customer service
- Data collected from reliable primary and secondary sources
- Highly trained and experienced team of research analysts
- Seamless delivery of tailor-made market research reports
Discounted prices for new customers! Offer expires soon!
Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-15958
Genomics Market: Segmentation
Valuable information covered in the FMI’s Genomics market report has been segregated into key segments and sub-segments.
By Application:
- Functional Genomics
- Real-time PCR
- Transfection
- SNP Analysis
- Mutational Analysis
- Microarray Analysis
- RNA Interference
- Pathway Analysis
- Microarray Analysis
- Bead-based Analysis
- Proteomics Tools
- Real-time PCR
- Mass Spectrometry
- Biomarker Discovery
- DNA Sequencing
- Microarray Analysis
- Real-time PCR
- Mass Spectrometry
- Other Biomarker Discoveries
- Epigenetics
- Bisulfite Sequencing
- Microarray Analysis
- Chromatin Immunoprecipitation
- Methylated DNA Immunoprecipitation
- Other Epigenetics
- Other Application & Technologies
By Deliverable:
- Products
- Services
By End-use:
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Academic and Government Institutes
- Clinical Research
- Other End Users
Genomics Market: Competition Analysis
The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Genomics market. Competitive information detailed in the Genomics market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Genomics market report.
Key players covered in the report include:
Thermo Fisher Scientific, Agilent Technologies, Beijing Genomics Institute, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina Inc., Oxford Nanopore Technologies, QIAGEN N.V., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Eppendorf AG, and Eurofins Scientific
Buy Now @ https://www.futuremarketinsights.com/checkout/15958
Important Questions Answered in the Genomics Market Report
- Which end user remains the top revenue contributor in different regional markets?
- At what rate has the global Genomics market been expanding during the forecast period?
- How will the global Genomics market look like by the end of the forecast period?
- What innovative strategies are adopted by Genomics market players to stay ahead of the pack?
- What are the restraints affecting the growth of the global Genomics market?
Key Offerings of the Report
- Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
- Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
- Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
- Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
- Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Genomics market
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs